RBC Europe’s Enlivex Therapeutics ENLV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-249	Closed	-$2.46K	–	778
2021 Q3	$2.46K	Hold	249	–	–	﹤0.01%	1106
2021 Q2	$2.22K	Hold	249	–	–	﹤0.01%	1117
2021 Q1	$2.76K	Buy	+249	New	+$2.76K	﹤0.01%	1050